Creative Antibiotics (former Innate Pharmaceuticals)

A drug discovery company that develops virulence blocking agents, a novel class of anti-infectives that may complement or replace antibiotics. The risk of bacteria developing a resistance to virulence blockers is probably low. The vision is to increase the global health by minimizing the problem with resistant bacteria.